Avalon GloboCare Reports Q3 2025 Progress with KetoAir(TM), Holistic Health Initiatives, and International Expansion
(NASDAQ:ALBT), FREEHOLD, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) — Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced a series of Q3 2025 advancements for KetoAir(TM), including expanded deployment, the launch of a first-responder metabolic health program, and entry into an international market. Key Highlights Launched […]